#GSK News

FEED

Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients

cnbc.com Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Inhalers will soon get a whole lot cheaper for some…

GSK Executive Sells Shares on LSE

tipranks.com has released an update. GlaxoSmithKline (GSK) has reported a transaction involving the sale of 3,551 ordinary shares by Sally...

Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?

finance.yahoo.com If you're an individual investor who wants to invest like a billionaire fund manager, I've got good news. Following billionaires is relatively easy because the U.S.…

A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now

finance.yahoo.com Does a rising tide really lift all boats? We could soon find out if the adage applies to the stock market. A bull market is now well underway. The S&P 500 has soared more…

Is Pfizer Stock, At A Nine-Year Low, A Sell Amid The Search For Its Big Break?

investors.com stock is trading at its lowest point in nine years as the drugmaker looks for its next big break after developing the first Covid vaccine with Germany's BioNTech (BNTX).…

Senator Bernie Sanders Applauds GSK's Move To Cap Inhaler Costs At $35 Per Month

benzinga.com On Wednesday, GSK Plc GSK announced it will cap out-of-pocket costs for eligible patients at no more than $35 per month for all its asthma and chronic obstructive pulmonary…

GSK to cap out-of-pocket inhaler costs in US

aol.com British pharmaceutical giant GSK said on Wednesday it would cap out-of-pocket costs for all its inhaled asthma and chronic lung disease medicines at $35 per month for…

Pfizer offloads $3.9 billion stake in Sensodyne-maker Haleon

finance.yahoo.com Haleon said on Tuesday top shareholder Pfizer offloaded a roughly $3.9 billion stake in the consumer healthcare firm, bringing down its holding in the British company to…

GSK Reveals New Phase 3 Data For Jemperli Combo Therapy To Support Expanded Use Approval For Wider Endometrial Cancer

benzinga.com Saturday, GSK plc GSK announced overall survival (OS) results from Part 1 and progression-free survival (PFS) results from Part 2 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase 3…

Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B

benzinga.com Pfizer Inc PFE plans to slash its stake to approximately 24% in Consumer healthcare giant Haleon Plc HLN This move follows Pfizer’s earlier announcement that it will…

Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%

finance.yahoo.com FILE PHOTO: The company logo for Haleon and the trading info is displayed on a screen on the floor of the NYSE in New York (Reuters) -Consumer healthcare firm Haleon said on…

AstraZeneca follows rival, will cap inhaler prices at $35 per month amid scrutiny

thehill.com Drugmaker AstraZeneca will cap out-of-pocket costs at $35 for all its inhaler products, the company announced Monday. The cap is effective June 1, and will apply to the…

Pfizer Plans to Sell About £2 Billion of Shares in Haleon

finance.yahoo.com Pfizer Inc. plans to sell about £2 billion ($2.5 billion) of shares in Haleon Plc, the first step by the UK consumer health company’s biggest shareholder to reduce its 32%…

The Entire Business World on a Single Page. Free to Use →